Your browser doesn't support javascript.
loading
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities.
Stacchiotti, Silvia; Frezza, Anna Maria; Blay, Jean-Yves; Baldini, Elizabeth H; Bonvalot, Sylvie; Bovée, Judith V M G; Callegaro, Dario; Casali, Paolo G; Chiang, RuRu Chun-Ju; Demetri, George D; Demicco, Elisabeth G; Desai, Jayesh; Eriksson, Mikael; Gelderblom, Hans; George, Suzanne; Gounder, Mrinal M; Gronchi, Alessandro; Gupta, Abha; Haas, Rick L; Hayes-Jardon, Andrea; Hohenberger, Peter; Jones, Kevin B; Jones, Robin L; Kasper, Bernd; Kawai, Akira; Kirsch, David G; Kleinerman, Eugene S; Le Cesne, Axel; Lim, Jiwon; Chirlaque López, María Dolores; Maestro, Roberta; Marcos-Gragera, Rafael; Martin Broto, Javier; Matsuda, Tomohiro; Mir, Olivier; Patel, Shreyaskumar R; Raut, Chandrajit P; Razak, Albiruni R A; Reed, Damon R; Rutkowski, Piotr; Sanfilippo, Roberta G; Sbaraglia, Marta; Schaefer, Inga-Marie; Strauss, Dirk C; Sundby Hall, Kirsten; Tap, William D; Thomas, David M; van der Graaf, Winette T A; van Houdt, Winan J; Visser, Otto.
Afiliação
  • Stacchiotti S; Department of Medical Oncology, National Cancer Institute of Milan, Milan, Italy.
  • Frezza AM; Department of Medical Oncology, National Cancer Institute of Milan, Milan, Italy.
  • Blay JY; Leon Berard Center, Claude Bernard University Lyon 1, UNICANCER Hospital Network, Lyon, France.
  • Baldini EH; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Bonvalot S; Department of Surgical Oncology, Curie Institute, University of Paris-Sciences and Letters, Paris, France.
  • Bovée JVMG; Department of Pathology, Leiden University Medical Center, Leiden, Netherlands.
  • Callegaro D; Department of Surgery, National Cancer Institute of Milan, Milan, Italy.
  • Casali PG; Department of Medical Oncology, National Cancer Institute of Milan, Milan, Italy.
  • Chiang RC; Taiwan Cancer Registry Center, Taipei, Taiwan.
  • Demetri GD; Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
  • Demicco EG; Department of Medical Oncology, Ludwig Center at Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Desai J; Department of Pathobiology and Laboratory Medicine, University of Toronto/Mount Sinai Hospital, Toronto, Ontario, Canada.
  • Eriksson M; Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
  • Gelderblom H; Department of Oncology, Skane University Hospital and Lund University, Lund, Sweden.
  • George S; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands.
  • Gounder MM; Department of Medical Oncology, Ludwig Center at Harvard Medical School, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Gronchi A; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Gupta A; Weill Cornell Medical College, New York, New York.
  • Haas RL; Department of Surgery, National Cancer Institute of Milan, Milan, Italy.
  • Hayes-Jardon A; Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Hohenberger P; Princess Margaret Cancer Center, Toronto, Ontario, Canada.
  • Jones KB; Department of Radiotherapy, Netherlands Cancer Institute, Amsterdam, Netherlands.
  • Jones RL; Department of Radiotherapy, Leiden University Medical Center, Amsterdam, Netherlands.
  • Kasper B; Department of Surgery, the Royal Marsden National Health Service Foundation Trust, London, United Kingdom.
  • Kawai A; Sarcoma Unit, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany.
  • Kirsch DG; Department of Orthopedics, University of Utah, Salt Lake City, Utah.
  • Kleinerman ES; Sarcoma Unit, Royal Marsden NHS Foundation Trust/Institute of Cancer Research, London, UK.
  • Le Cesne A; Sarcoma Unit, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany.
  • Lim J; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Chirlaque López MD; Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
  • Maestro R; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Marcos-Gragera R; Medical Oncology, Gustave Roussy Institute, Villejuif, Ile-de-France, France.
  • Martin Broto J; Division of Cancer Registration and Surveillance, National Cancer Center, Ilsandong-gu, Goyang-si, Republic of Korea.
  • Matsuda T; Department of Epidemiology, Regional Health Council, Biomedical Research Institute of Murcia-Arrixaca, Murcia University, Murcia, Spain.
  • Mir O; Unit of Oncogenetics and Functional Oncogenomics, Aviano IRCCS Oncology Referral Center, Aviano, Italy.
  • Patel SR; Epidemiology Unit and Girona Cancer Registry, Oncology Coordination Plan, Department of Health, Autonomous Government of Catalonia, Catalan Institute of Oncology, Girona, Spain.
  • Raut CP; Medical Oncology Department, University Hospital Virgen del Rocio, Sevilla, Spain.
  • Razak ARA; National Cancer Registry Section, Center for Cancer Registries, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan.
  • Reed DR; Medical Oncology, Gustave Roussy Institute, Villejuif, Ile-de-France, France.
  • Rutkowski P; Department of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Sanfilippo RG; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
  • Sbaraglia M; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Schaefer IM; Princess Margaret Cancer Center, Toronto, Ontario, Canada.
  • Strauss DC; Department of Interdisciplinary Cancer Management, Moffitt Cancer Center, Tampa, Florida.
  • Sundby Hall K; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Tap WD; Department of Medical Oncology, National Cancer Institute of Milan, Milan, Italy.
  • Thomas DM; Department of Pathology, University Hospital of Padova, Padova, Italy.
  • van der Graaf WTA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • van Houdt WJ; Sarcoma Unit, Royal Marsden NHS Foundation Trust/Institute of Cancer Research, London, UK.
  • Visser O; Department of Oncology, the Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Cancer ; 127(16): 2934-2942, 2021 08 15.
Article em En | MEDLINE | ID: mdl-33910263
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles Tipo de estudo: Diagnostic_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles Tipo de estudo: Diagnostic_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Itália